Transcription factor AP-2 Beta, a potential target of repetitive Transspinal magnetic stimulation in spinal cord injury treatment, reduced inflammation and alleviated spinal cord injury med./bio.

Published in: Exp Neurol 2025; 386: 115144

Exposure